May 29, 2008:  Financial Results

Ipca Laboratories Ltd. (Ipca) has posted improved financial results for the year ended 31st March, 2008. The total income for the year has gone up by 17% to Rs.1085.14 crores as against Rs.924.84 crores in the previous financial year. Export Sales for the year increased by 11% to Rs.536.00 crores.

The Net Profit for the financial year has increased by 15% to Rs.141.12 crores  as against Rs.122.23 crores in the previous year. The Earning Per Share works out to Rs.56.38 per share of Rs.10/- each .

The Board has recommended a final  dividend of 45% (Rs.4.50 per share) for the financial year 2007-08. Together with the interim dividend of 35% already declared and paid, the total dividend for the financial year amounts to 80% (Rs.8 per share) as against 75% (Rs.7.50 per share) in the previous year.

2007- 08 Audited Results at a glance

 

(Rs. Crores)
Year ended	31.03.2008	31.03.2007	Growth
Net Total Income	1085.14	924.84	17 %
Export Income	536.00	484.46	11%
Profit before Tax	176.87	150.40	18%
Net Profit	141.12	122.23	15%
Earnings per share of Rs.10/- (Rs.)	56.38	48.89	15%

 

(Rs. Crores)
4th Quarter ended	31.03.2008	31.03.2007	Growth
Net Total Income	255.10	225.06	13%
Export Income	147.09	144.35	2%
Profit before Tax	24.74	28.50	(13%)
Net Profit	22.64	27.65	(18%)
Earnings per share of Rs.10/- (Rs.)	9.04	11.06	(18%)

The manufacturing operations of the Company's Athal formulations manufacturing unit was affected in the 4th quarter due to a incidence of fire in the stores. The fire damaged the raw materials which were fully insured. However, the raw materials replacement and its testing time, upset  the production schedule and resultant exports. Athal manufacturing unit is the Company's largest formulations manufacturing unit for the exports market.

Ipca Laboratories is a backward integrated, fast growing pharmaceutical major, with a strong thrust on exports. Exports to over 110 countries, now account for nearly 50% of Company's income.

Premchand Godha
Managing Director

Encl: Audited Financial Results.

For further editorial content please contact :

Mr. A.K. Jain, Executive Director

Ipca Laboratories Ltd.

Tel : 6647 4654
ajit@ipca.co.in

Back